
Johnson & Johnson
NYSE:JNJ

Intrinsic Value
The intrinsic value of one
JNJ
stock under the Base Case scenario is
160.09
USD.
Compared to the current market price of 165.49 USD,
Johnson & Johnson
is
Overvalued by 3%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Johnson & Johnson
Fundamental Analysis

Continued legal challenges, especially around talc-based products and opioid-related lawsuits, could result in substantial settlement costs and negatively impact Johnson & Johnson’s reputation and cash flow.
Its diversified portfolio across pharmaceuticals, medical devices, and consumer health products insulates Johnson & Johnson from downturns in any single category, supporting stable revenue and cash generation.

Revenue & Expenses Breakdown
Johnson & Johnson
Balance Sheet Decomposition
Johnson & Johnson
Current Assets | 55.9B |
Cash & Short-Term Investments | 24.5B |
Receivables | 14.8B |
Other Current Assets | 16.5B |
Non-Current Assets | 124.2B |
Long-Term Investments | 451m |
PP&E | 21.6B |
Intangibles | 81.8B |
Other Non-Current Assets | 20.3B |
Free Cash Flow Analysis
Johnson & Johnson
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Johnson & Johnson
Revenue
|
88.8B
USD
|
Cost of Revenue
|
-27.4B
USD
|
Gross Profit
|
61.4B
USD
|
Operating Expenses
|
-37.9B
USD
|
Operating Income
|
23.5B
USD
|
Other Expenses
|
-9.4B
USD
|
Net Income
|
14.1B
USD
|
JNJ Profitability Score
Profitability Due Diligence
Johnson & Johnson's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

Score
Johnson & Johnson's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
JNJ Solvency Score
Solvency Due Diligence
Johnson & Johnson's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Score
Johnson & Johnson's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
JNJ Price Targets Summary
Johnson & Johnson
According to Wall Street analysts, the average 1-year price target for
JNJ
is 172.4 USD
with a low forecast of 151.5 USD and a high forecast of 199.5 USD.
Dividends
Current shareholder yield for JNJ is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
JNJ
stock under the Base Case scenario is
160.09
USD.
Compared to the current market price of 165.49 USD,
Johnson & Johnson
is
Overvalued by 3%.